Bill Marth just said they expect an answer by end of January. However, he doesn't know what that answer will be (whether more info needed on immunogenicity, other data, approval, etc). It sure sounds like he's conceded the app is going to be held up. For the first time his confidence his waning.
Market Data 
Markets 
AI
